SCHEMBL26763228

SCHEMBL26763228

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)oc4cc(-c6cc(-c7ccccc7)cc7c6oc6ccccc67)ccc45)n3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.42
▸ PRKDC P78527 1/20 0.39
▸ PLA2G2A P14555 3/20 0.38
▸ PLA2G4A P47712 3/20 0.38
▸ PLA2G10 O15496 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MAPT P10636 5/20 0.37
▸ POLB P06746 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ HCRTR1 O43613 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ CSNK2A2 P19784 1/20 0.36
▸ CSNK2B P67870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26763510 1.00 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL26763518 1.00 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL26222136 0.98 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL19860909 0.98 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL26225359 0.98 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL26763530 0.98 ALOX5 (0.41) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL26763225 0.98 ALOX5 (0.40) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL20739861 0.96 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4AMMP12
SCHEMBL26762967 0.96 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4AMMP12
SCHEMBL26214883 0.96 ALOX5 (0.42) ALOX5PRKDCPLA2G2APLA2G4AMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 — — US disclosed
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357209-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, ODC1 ALOX5 309/4885PRKDC 4160/4885PLA2G2A 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback